T1	HMM 613 641	The median serum MMP-8 level
T2	HMM 755 779	subgroup, IFN-α therapy
T3	HMM 794 831	improved relapse-free survival (RFS).
T4	HMM 869 886	high MMP-8 levels
T5	HMM 913 920	whereas
T6	HMM 940 957	high MMP-8 levels
T7	HMM 1001 1008	0.027).
T8	HMM 1009 1032	Median overall survival
T9	HMM 1051 1061	high MMP-8
T10	HMM 1167 1188	model, IFN-α therapy
T11	HMM 1220 1229	favorable
T12	HMM 1600 1621	with high serum MMP-8
